NCT06375447 Intelligent Diagnosis and Treatment Model for Insomnia Disorder
| NCT ID | NCT06375447 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xuanwu Hospital, Beijing |
| Condition | Insomnia |
| Study Type | OBSERVATIONAL |
| Enrollment | 16,000 participants |
| Start Date | 2022-12-01 |
| Primary Completion | 2025-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 16,000 participants in total. It began in 2022-12-01 with a primary completion date of 2025-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To establish a multicenter, multi-dimensional cohort on insomnia disorder and to develop an intelligent model for the diagnosis and treatment of insomnia disorder.
Eligibility Criteria
Inclusion Criteria: 1. A complaint of insomnia; 2. Age between 18 and 75; 3. Able to fill out the scale on their own; 4. Agree to sign the informed consent to participate in the study and cooperate in completing the follow-up visit. Exclusion Criteria: 1.A current or history of comorbid Axis I psychiatric disorders.
Contact & Investigator
Hongxing Wang, MD & PhD
STUDY DIRECTOR
Xuanwu Hospital, Beijing
Frequently Asked Questions
Who can join the NCT06375447 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Insomnia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06375447 currently recruiting?
Yes, NCT06375447 is actively recruiting participants. Contact the research team at wanghuang1118@163.com for enrollment information.
Where is the NCT06375447 trial being conducted?
This trial is being conducted at Beijing, China, Beijing, China, Changchun, China, Chengdu, China and 1 additional location.
Who is sponsoring the NCT06375447 clinical trial?
NCT06375447 is sponsored by Xuanwu Hospital, Beijing. The principal investigator is Hongxing Wang, MD & PhD at Xuanwu Hospital, Beijing. The trial plans to enroll 16,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.